SUPHA PHARMACHEM LIMITED (SUPHA)

BSE: ₹0.34
Back to Home
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Mar 2025 Jun 2025 Sep 2025
Revenue from Operations 264.32 113.37 111.06
YOY Revenue Growth % - - -
Other Income 0.66 3.48 3.25
Total Income 264.98 116.84 114.31
Total Expenses + 266.38 111.13 103.88
Cost of Materials Consumed 0.00 0.00 0.00
Employee Benefit Expense 0.09 0.20 0.19
Other Expenses 2.02 3.47 3.02
Operating Profit -2.06 2.24 7.18
OPM % -0.8% 2% 6.5%
Profit Before Tax + -1.40 5.71 10.44
Tax Expense 0.65 1.06 1.81
Tax % - 18.6% 17.4%
Profit After Tax -2.05 4.65 8.62
EPS (Basic) -0.05 0.05 0.10

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025
Revenue from Operations 405.25
YOY Revenue Growth % -
Other Income 10.80
Total Income 416.05
Total Expenses + 411.67
Employee Benefit Expense 0.76
Other Expenses 7.45
Operating Profit -6.42
OPM % -1.6%
Profit Before Exceptional 4.38
Exceptional Items 0.00
Profit Before Tax + 4.38
Tax Expense 2.25
Tax % 51.4%
Profit After Tax 2.13
EPS (Basic) 0.05

Balance Sheet

Particulars Mar 2025
ASSETS
Non-Current Assets + 0.04
Property, Plant & Equipment 0.01
Capital Work in Progress 0.00
Non-Current Investments 0.00
Goodwill 0.00
Other Intangible Assets 0.00
Current Assets + 1,720.31
Inventories 269.38
Trade Receivables 771.62
Cash and Cash Equivalents 0.28
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 43.89
Equity Share Capital 40.32
Other Equity 3.57
Non-Current Liabilities 0.00
Current Liabilities 1,676.46
Total Liabilities 1,676.46

Cash Flow Statement

Particulars Mar 2025
Cash from Operating Activities -1,134.81
Cash from Investing Activities 0.13
Cash from Financing Activities 1,136.10
Net Increase/Decrease in Cash 1.43